Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia

Completed · Phase 3

Conditions studied: Pneumonia

In brief

The purpose of this study is to determine whether tifacogin is effective and safe in the treatment of patients with severe community-acquired pneumonia.

Key facts

Study ID

NCT00084071

Run by

Novartis Pharmaceuticals

People needed

2136

Starts

2004-05-01

Expected to finish

2008-07-01

Last updated by the study team

2020-12-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of community-acquired pneumonia supported by additional clinical, radiological, and microbiological evidence
• Pneumonia of sufficient severity to require ICU admission and management

You may not qualify if…

• Pregnancy
• Weight over 150 kg
• Patients at increased risk of bleeding
• Treatment with drotrecogin alfa or anticipated need for drotrecogin alfa
• Treatment with heparin or anticipated need for heparin

Where it is running

• Study site — Loma Linda, California, United States
• Study site — Los Angeles, California, United States
• Study site — Orange, California, United States
• Study site — Sacramento, California, United States
• Study site — San Diego, California, United States
• Study site — San Jose, California, United States
• Study site — Denver, Colorado, United States
• Study site — Farmington, Connecticut, United States
• Study site — New Haven, Connecticut, United States
• Study site — Newark, Delaware, United States
• Study site — Bay Pines, Florida, United States
• Study site — Clearwater, Florida, United States
• Study site — Fort Lauderdale, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Conyers, Georgia, United States
• Study site — Decatur, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Oak Park, Illinois, United States
• Study site — Muncie, Indiana, United States
• Study site — New Albany, Indiana, United States
• Study site — Shreveport, Louisiana, United States
• Study site — Baltimore, Maryland, United States
• Study site — Cumberland, Maryland, United States
• Study site — Mobile, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.